SAPACITABINE
UNII W335P73C3L

Substance Identification & Data

This profile provides standardized clinical and technical data for Sapacitabine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W335P73C3L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 151823-14-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W335P73C3L

CAS Registry Number

151823-14-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SAPACITABINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H42N4O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LBGFKUUHOPIEMA-PEARBKPGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C64541

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

153970

Unique identification number in the NCBI database of chemical substances.

INN ID

8672

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-161

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1([C@H]2[C@H]([C@H](O)[C@H](O2)CO)C#N)c(nc(cc1)NC(=O)CCCCCCCCCCCCCCC)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sapacitabine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.